Using the Roots of a Non Restorable Wisdom Tooth as a Block for Augmentation of Localized Defects
Launched by AIN SHAMS UNIVERSITY · Feb 11, 2020
Trial Information
Current as of April 30, 2025
Unknown status
Keywords
ClinConnect Summary
A total of 14 patients in need of implant therapy and lateral ridge augmentation were allocated to parallel groups receiving either 1) healthy autogenous tooth roots (e.g. retained wisdom or impacted teeth or 2) cortical autogenous bone blocks harvested from the retromolar area. After 26 weeks of submerged healing the horizontal bone gain were assessed both clinically and radiographically. A core biopsy was taken during the implant placement to assess the histology of the newly formed bone.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Candidate for lateral ridge augmentation
- • 2. Insufficient bone ridge width at the recipient site for implant placement
- • 3. Sufficient bone height at the recipient site for implant placement
- • 4. Healthy oral mucosa, at least 3 mm keratinized tissue.
- • 5. Presence of wisdom teeth free from periapical infection.
- • 6. Missing maxillary or mandibular tooth with moderate horizontal defect (4-8) according to cologne classification
- Exclusion Criteria:
- • 1) Patients are systemically free according to Modified Cornell Medical Index 2) smokers patients. 3) Pregnant or lactating women.
About Ain Shams University
Ain Shams University, established in Cairo, Egypt, is a prestigious higher education institution renowned for its commitment to academic excellence and research innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise in various medical and scientific disciplines to advance healthcare through rigorous research initiatives. With a focus on ethical practices and adherence to regulatory standards, Ain Shams University aims to contribute to the development of new therapies and improve patient outcomes, fostering collaboration among researchers, healthcare professionals, and industry partners in the pursuit of medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, Abbassia, Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials